Page last updated: 2024-08-24

1,5-anhydroglucitol and empagliflozin

1,5-anhydroglucitol has been researched along with empagliflozin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Adamski, J; Artati, A; Federici, M; Ghesquiere, B; Kappel, BA; Lehrke, M; Marx, N; Moellmann, J; Rau, M; Romeo, F; Schuett, K; Stoehr, R; Thiele, K	1

Other Studies

1 other study(ies) available for 1,5-anhydroglucitol and empagliflozin

Article	Year
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker. Clinical and translational medicine, 2021, Volume: 11, Issue:6 Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors	2021

Article

Year

Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.

Clinical and translational medicine, 2021, Volume: 11, Issue:6

Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2021